Cetuximab+mFOLFOX6 VS. mFOLFOX6 Alone in RAS/BRAF Wild Type Patients With High-Risk Resectable CRLM
Clinical trial NCT05948072 · UNKNOWN
Trial details
- NCT number
- NCT05948072
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-15
- Primary completion
- 2026-07-15
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.